Advertisement
Screener

Citadel Advisors LLC Historic Quarter Change: Foreign ADRs, Sold Out, 2020 Q4

CITADEL ADVISORS LLC historic quarter change: Foreign ADRs, Sold out

In depositary receipts for foreign shares (depositary receipts and foreign shares traded over the counter), over 51 quarters from 2013-06-30 to 2026-03-31, CITADEL ADVISORS LLC opened 793 positions, added to 554, reduced 514 and sold out of 741.

  • Q4 2020: Stock ORPHAZYME A S; Country of operation —; Class ADS; Shares before 200,000.
  • Q4 2020: Stock CHINDATA GROUP HLDGS LTD; Country of operation —; Class ADS; Shares before 100,573.
  • Q4 2020: Stock BITAUTO HLDGS LTD; Country of operation —; Class SPONSORED ADS; Shares before 83,018.
  • Q4 2020: Stock MESOBLAST LTD; Country of operation —; Class SPONS ADR; Shares before 45,471.

Each consecutive pair of Form 13F-HR filings compared (SEC CIK 1423053), 51 quarters: Q1 2026 (2025-12-31 to 2026-03-31, filed 2026-05-15); Q4 2025 (2025-09-30 to 2025-12-31, filed 2026-02-17); Q3 2025 (2025-06-30 to 2025-09-30, filed 2025-11-14); Q2 2025 (2025-03-31 to 2025-06-30, filed 2025-08-14); Q1 2025 (2024-12-31 to 2025-03-31, filed 2025-05-15); Q4 2024 (2024-09-30 to 2024-12-31, filed 2025-02-14); Q3 2024 (2024-06-30 to 2024-09-30, filed 2024-11-14); Q2 2024 (2024-03-31 to 2024-06-30, filed 2024-08-14); Q1 2024 (2023-12-31 to 2024-03-31, filed 2024-05-15); Q4 2023 (2023-09-30 to 2023-12-31, filed 2024-02-14); Q3 2023 (2023-06-30 to 2023-09-30, filed 2023-11-14); Q2 2023 (2023-03-31 to 2023-06-30, filed 2023-08-14); Q1 2023 (2022-12-31 to 2023-03-31, filed 2023-05-15); Q4 2022 (2022-09-30 to 2022-12-31, filed 2023-02-14); Q3 2022 (2022-06-30 to 2022-09-30, filed 2022-11-14); Q2 2022 (2022-03-31 to 2022-06-30, filed 2022-08-15); Q1 2022 (2021-12-31 to 2022-03-31, filed 2022-05-16); Q4 2021 (2021-09-30 to 2021-12-31, filed 2022-02-14); Q3 2021 (2021-06-30 to 2021-09-30, filed 2021-11-15); Q2 2021 (2021-03-31 to 2021-06-30, filed 2021-08-16); Q1 2021 (2020-12-31 to 2021-03-31, filed 2021-05-17); Q4 2020 (2020-09-30 to 2020-12-31, filed 2021-02-16); Q3 2020 (2020-06-30 to 2020-09-30, filed 2020-11-16); Q2 2020 (2020-03-31 to 2020-06-30, filed 2020-08-14); Q1 2020 (2019-12-31 to 2020-03-31, filed 2020-05-15); Q4 2019 (2019-09-30 to 2019-12-31, filed 2020-02-14); Q3 2019 (2019-06-30 to 2019-09-30, filed 2019-11-14); Q2 2019 (2019-03-31 to 2019-06-30, filed 2019-08-14); Q1 2019 (2018-12-31 to 2019-03-31, filed 2019-05-15); Q4 2018 (2018-09-30 to 2018-12-31, filed 2019-02-14); Q3 2018 (2018-06-30 to 2018-09-30, filed 2018-11-13); Q2 2018 (2018-03-31 to 2018-06-30, filed 2018-08-10); Q1 2018 (2017-12-31 to 2018-03-31, filed 2018-05-11); Q4 2017 (2017-09-30 to 2017-12-31, filed 2018-02-09); Q3 2017 (2017-06-30 to 2017-09-30, filed 2017-11-09); Q2 2017 (2017-03-31 to 2017-06-30, filed 2017-08-11); Q1 2017 (2016-12-31 to 2017-03-31, filed 2017-05-12); Q4 2016 (2016-09-30 to 2016-12-31, filed 2017-02-10); Q3 2016 (2016-06-30 to 2016-09-30, filed 2016-11-10); Q2 2016 (2016-03-31 to 2016-06-30, filed 2016-08-12); Q1 2016 (2015-12-31 to 2016-03-31, filed 2016-05-13); Q4 2015 (2015-09-30 to 2015-12-31, filed 2016-02-12); Q3 2015 (2015-06-30 to 2015-09-30, filed 2015-11-16); Q2 2015 (2015-03-31 to 2015-06-30, filed 2015-08-14); Q1 2015 (2014-12-31 to 2015-03-31, filed 2015-05-15); Q4 2014 (2014-09-30 to 2014-12-31, filed 2015-02-18); Q3 2014 (2014-06-30 to 2014-09-30, filed 2014-11-14); Q2 2014 (2014-03-31 to 2014-06-30, filed 2014-08-14); Q1 2014 (2013-12-31 to 2014-03-31, filed 2014-05-15); Q4 2013 (2013-09-30 to 2013-12-31, filed 2014-02-14); Q3 2013 (2013-06-30 to 2013-09-30, filed 2013-11-14). Rows for the same security, class and put/call are added together. Value change is the filed value at each quarter end, so it includes the price move. Only the filings held here are compared; the firm's 13F-HR filings go back to the quarter ended 2009-12-31.

QuarterStockCountry of operationClassShares beforeShares afterShare changeValue beforeValue afterValue changeFiled
Q4 2020ORPHAZYME A S
CUSIP 687305102
—ADS200,0000-200,000$2,066$0-$2,0662021-02-16
Q4 2020CHINDATA GROUP HLDGS LTD
CUSIP 16955F107
—ADS100,5730-100,573$1,632$0-$1,6322021-02-16
Q4 2020BITAUTO HLDGS LTD
CUSIP 091727107
—SPONSORED ADS83,0180-83,018$1,308$0-$1,3082021-02-16
Q4 2020MESOBLAST LTD
CUSIP 590717104
—SPONS ADR45,4710-45,471$844$0-$8442021-02-16
Q4 2020TELEFONICA BRASIL SA
CUSIP 87936R106
—SPONSORED ADR79,6630-79,663$611$0-$6112021-02-16
Q4 2020HEADHUNTER GROUP PLC
CUSIP 42207L106
—SPONSORED ADS20,6470-20,647$506$0-$5062021-02-16
Q4 2020COMPANHIA BRASILEIRA DE DIST
CUSIP 20440T300
—SPONSORED ADR35,9760-35,976$444$0-$4442021-02-16
Q4 2020PETROCHINA CO LTD
CUSIP 71646E100
—SPONSORED ADR13,9800-13,980$412$0-$4122021-02-16
Q4 2020LINE CORP
CUSIP 53567X101
—SPONSORED ADR7,9370-7,937$403$0-$4032021-02-16
Q4 2020FREELINE THERAPEUTICS HLDGS
CUSIP 35655L107
—SPONSORED ADS25,5420-25,542$398$0-$3982021-02-16
Q4 2020ONECONNECT FINL TECHNOLOGY C
CUSIP 68248T105
—SPONSORED ADS17,1750-17,175$366$0-$3662021-02-16
Q4 2020TIM PARTICIPACOES S A
CUSIP 88706P205
—SPONSORED ADR25,0250-25,025$289$0-$2892021-02-16
Q4 2020REDHILL BIOPHARMA LTD
CUSIP 757468103
—SPONSORED ADS23,4560-23,456$240$0-$2402021-02-16
Q4 2020CHINA SOUTHERN AIRLINES CO L
CUSIP 169409109
—SPON ADR CL H7,8330-7,833$213$0-$2132021-02-16
Q4 2020TIZIANA LIFE SCIENCES PLC
CUSIP 88875G101
—SPONSORED ADS36,9240-36,924$124$0-$1242021-02-16
Q4 2020CANGO INC
CUSIP 137586103
—ADS20,2120-20,212$112$0-$1122021-02-16
Q4 2020TRINITY BIOTECH PLC
CUSIP 896438306
—SPON ADR NEW52,2790-52,279$105$0-$1052021-02-16
Q4 2020CHINA DISTANCE ED HLDGS LTD
CUSIP 16944W104
—SPONS ADR10,0540-10,054$96$0-$962021-02-16
Q4 2020GUANGSHEN RY LTD
CUSIP 40065W107
—SPONSORED ADR11,3280-11,328$95$0-$952021-02-16
Q4 2020MEDIGUS LTD
CUSIP 58471G300
—SPONSORED ADS50,6110-50,611$70$0-$702021-02-16
Q4 2020BRIGHT SCHOLAR ED HLDGS LTD
CUSIP 109199109
—SPONSORED ADS10,4540-10,454$67$0-$672021-02-16
Q4 2020GRIDSUM HLDG INC
CUSIP 398132100
—SPONSORED ADR44,2990-44,299$54$0-$542021-02-16
Q4 2020RENESOLA LTD
CUSIP 75971T301
—SPONSORED ADS25,0950-25,095$52$0-$522021-02-16
Q4 2020JIANPU TECHNOLOGY INC
CUSIP 47738D101
—ADR58,2540-58,254$30$0-$302021-02-16
Q4 2020CAN FITE BIOFARMA LTD
CUSIP 13471N201
—SPONSORED ADS11,8720-11,872$21$0-$212021-02-16
Q4 2020TUANCHE LTD
CUSIP 89856T104
—ADS13,9120-13,912$11$0-$112021-02-16